Alzamend Neuro

(NASDAQ) ALZN

Current Price$1.03

Market Cap$3.88M

Since IPO (2021)-100%

5 YearN/A

1 Year-69%

1 Month+0%

Alzamend Neuro Financials at a Glance

Market Cap

$3.88M

Revenue (TTM)

$0.00

Net Income (TTM)

$7.04M

EPS (TTM)

$-4.38

P/E Ratio

-0.23

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.03

Volume

238

Open

$1.01

Price

$1.03

Volume

238

Open

$1.01

Previous Close

$1.03

Daily Range

$1.01 - $1.03

52-Week Range

$0.84 - $8.22

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.03

Volume

238

Open

$1.01

Previous Close

$1.03

Daily Range

$1.01 - $1.03

52-Week Range

$0.84 - $8.22

ALZN News

Medical researchers - GettyImages-1213006106

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Alzamend Neuro

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Stephan Jackman

Website

www.alzamend.com

Headquarters

Atlanta, GA 30326, US

ALZN Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-250%

Return on Capital

-3%

Return on Assets

-2%

Earnings Yield

-4.35%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.88M

Shares Outstanding

3.80M

Volume

238

Avg. Volume

130.51K

Financials (TTM)

Gross Profit

$50.74K

Operating Income

$4.50M

EBITDA

$4.45M

Operating Cash Flow

$6.57M

Capital Expenditure

$300.00K

Free Cash Flow

$6.87M

Cash & ST Invst.

$3.95M

Total Debt

$0.00

Alzamend Neuro Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$27.68K

-118.2%

Gross Margin

0.00%

N/A

Market Cap

$3.88M

N/A

Market Cap/Employee

$970.20K

N/A

Employees

N/A

Net Income

$2.20M

-111.6%

EBITDA

$2.17M

-111.7%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Net Cash

$2.71M

-19.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.74%

N/A

Return on Invested Capital

-3.22%

N/A

Free Cash Flow

$1.74M

-22.0%

Operating Cash Flow

$1.74M

-22.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ACXPAcurx Pharmaceuticals, Inc.

ACXPAcurx Pharmaceuticals, Inc.$1.80-6.25%

HCWBHCW Biologics Inc.

HCWBHCW Biologics Inc.$1.34+9.84%

CDIOCardio Diagnostics Holdings, Inc.

CDIOCardio Diagnostics Holdings, Inc.$1.39-10.32%

BCDABioCardia, Inc.

BCDABioCardia, Inc.$0.90-10.88%

APREAprea Therapeutics, Inc.

APREAprea Therapeutics, Inc.$0.85-9.13%

CELZCreative Medical Technology Holdings, Inc.

CELZCreative Medical Technology Holdings, Inc.$2.23-0.45%

ADILAdial Pharmaceuticals, Inc.

ADILAdial Pharmaceuticals, Inc.$1.61+16.67%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.74-0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.20-0.06%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$74.32-0.01%

TET1 Energy Inc.

TET1 Energy Inc.$7.00+0.23%

ONDSOndas

ONDSOndas$9.70-0.09%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.54+0.01%

POETPoet Technologies

POETPoet Technologies$14.21-0.11%

Questions About ALZN

What is the current price of Alzamend Neuro?

Alzamend Neuro is trading at $1.03 per share.

What is the 52-week range for Alzamend Neuro?

Over the past 52 weeks, Alzamend Neuro has traded between $0.84 and $8.22.

How much debt does Alzamend Neuro have?

As of the most recent reporting period, Alzamend Neuro reported total debt of N/A.

How much cash does Alzamend Neuro have on hand?

Alzamend Neuro reported $2.71M in cash and cash equivalents in its most recent financial results.

What is Alzamend Neuro’s dividend yield?

Alzamend Neuro does not currently have a dividend yield.

Alzamend Neuro

Alzamend Neuro Financials at a Glance

ALZN News

Why Alzamend Neuro Stock Soared Today

Why Alzamend Neuro Stock Fell More Than 14% Today

Here's Why Alzamend Neuro Stock Is Shooting Higher Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Alzamend Neuro

ALZN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Alzamend Neuro Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ALZN

What is the current price of Alzamend Neuro?

What is the 52-week range for Alzamend Neuro?

How much debt does Alzamend Neuro have?

How much cash does Alzamend Neuro have on hand?

What is Alzamend Neuro’s dividend yield?

Premium Investing Services